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        Similarity of Shiga 
Toxin–producing 
Escherichia coli 
O104:H4 Strains 
from Italy 
and Germany
To the Editor: Since the beginning 
of May 2011, a large outbreak of 
infections associated with Shiga toxin 
(Stx)–producing  Escherichia coli 
(STEC) O104:H4 has occurred in 
Germany (1). The outbreak showed 3 
unusual features: 1) a large proportion 
of case-patients with hemolytic 
uremic syndrome (HUS); 2) HUS 
in adults, although it usually affects 
children; and 3) frequent development 
of neurologic symptoms in patients 
when clinical and laboratory markers 
of HUS were improving (1,2). A 
second point-source outbreak caused 
by the same STEC O104 strain was 
reported in June 2011 in France (3). 
Both outbreaks were linked to eating 
fenugreek sprouts obtained from seeds 
produced in Egypt and distributed 
in Germany and other European 
countries (4).
Instead of the attaching–effacing 
mechanism of adhesion to intestinal 
mucosa that is typical of STEC 
associated with severe human disease 
(5), the STEC O104 epidemic strain 
had genetic markers and an adhesion 
pattern (6) typical of enteroaggregative 
E. coli (EAEC), another group of 
diarrheagenic strains found frequently 
in developing countries (5).
On basis of these ﬁ  ndings,  we 
reviewed our culture collection and 
found that an STEC strain (ED-703) 
from a case-patient with HUS in 2009 
in Italy had the same combination 
of virulence factors as the strain 
from Germany: Stx2 production and 
enteroaggregative adhesion genetic 
markers. This strain, which had not 
been typed when it was isolated, 
showed positive PCR results for O104 
(7) and H4 (8) antigen–associated 
genes and was agglutinated by an O104 
antiserum (Statens Serum Institut, 
Copenhagen, Denmark). Pulsed-ﬁ  eld 
gel electrophoresis showed a high 
degree of similarity (94.7%) with 
the outbreak strain from Germany 
(provided by M. Mielke, Robert 
Koch Institute, Berlin, Germany). 
In contrast with the outbreak strain, 
ED-703 did not produce extended-
spectrum β-lactamases.
The strain from our culture 
collection had been isolated from 
a 9-year-old girl admitted to the 
pediatric nephrology unit of the 
Ospedale Maggiore (Milan, Italy) on 
August 5, 2009, after 5 days of bloody 
diarrhea, vomiting, and abdominal 
pain. Diagnosis of HUS was based 
on the presence of hemolytic anemia, 
thrombocytopenia, and anuria. 
Neurologic symptoms (e.g., lethargy, 
diplopia, and nystagmus) occurred 
during hospitalization; magnetic 
resonance imaging showed signal 
abnormalities in the lenticular nuclei.
Because of severe cardiac 
impairment with ejection fraction 
reduction and troponin increase, 
inotropic support and mechanical 
ventilation were temporarily needed. 
After improvement of clinical 
conditions, the patient was discharged, 
but she was readmitted a few days 
later because of headache, vomiting, 
confusion, dysarthria, hypertension, 
and visual impairment. Ischemic 
lesions were found by magnetic 
resonance imaging at fundus oculi. 
Neurologic status improved the next 
day, but the visual deﬁ  cit  persisted. 
Hemodialysis was needed for 2 
months. Long-term sequelae of the 
disease were stage IV chronic kidney 
disease, hypertension, and severe 
visual impairment.
Informed consent and an 
epidemiologic interview were 
obtained from the patient’s parents. 
The household, including her mother 
and 2 siblings (4 and 5 years of age), 
had traveled for 1 week to a resort in 
Tunisia; they had returned 3 weeks 
before the onset of the prodromal 
symptoms of HUS. Four days after 
their return, the youngest sister was 
hospitalized for 3 days because of 
bloody diarrhea, but no laboratory 
diagnosis was established. The mother 
reported having had watery diarrhea 
and abdominal pain on August 2. The 
patient history did not show any other 
usual risk factor for STEC infection, 
such as consumption of unpasteurized 
milk or dairy products, undercooked 
meat, or raw sprouts or direct exposure 
to ruminants or their manure. This 
ﬁ  nding suggests that the infection was 
probably acquired through person-to-
person transmission.
This case report conﬁ  rms  that 
strains of STEC O104 strictly related 
to the epidemic strain in Germany had 
already caused sporadic infections in 
Europe (9). Other cases have been 
documented in 2001 in Germany (6,9), 
in 2004 in France (9), and in 2010 in 
Finland in a patient with diarrhea who 
had traveled to Egypt (9). Both of 
the cases for which the information 
on the origin of the infection was 
available were related to travel to 
northern Africa, from which the seeds 
associated with both outbreaks could 
be traced (4).
The history of this patient 
supports the hypothesis that ruminants 
would not have had a speciﬁ  c 
role in the transmission of STEC 
O104:H4, as already suggested by the 
epidemiologic features of the recent 
outbreaks (1,3). In fact, STEC O104 
cannot be considered true STEC but 
rather EAEC strains that acquired the 
Stx2-coding phages by horizontal gene 
transfer, and EAEC is considered to be 
a human pathogen usually transmitted 
by the oral–fecal route (5).
The clinical course of our patient 
closely resembles those of persons 
who had HUS associated with the 
German outbreak (1,2). The unusual 
combination of virulence factors of 
STEC and EAEC, already described 
in a group of STEC O111:H2 from an 
outbreak of HUS in France in 1996 
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(10), might confer a high degree of 
virulence to these strains. It also might 
explain the severity of the clinical 
ﬁ   ndings associated with STEC 
O104:H4 infections.
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Complicated 
Pandemic (H1N1) 
2009 during 
Pregnancy, Taiwan
To the Editor: Pregnant women 
with pandemic (H1N1) 2009 virus 
infection are at increased risk for 
severe illness and complications (1–
3). Recent reports have shown that 
this infection causes disproportionate 
illness and death in pregnant women 
and has been associated with adverse 
fetal and neonatal outcomes. We 
characterized the severity of pandemic 
(H1N1) 2009 virus infection among 
pregnant women in Taiwan.
Complicated inﬂ  uenza infection, 
deﬁ   ned as inﬂ   uenza-like illness and 
evidence of pneumonia, neurologic 
symptoms, myopericarditis, or 
invasive bacterial infections, has 
been a notiﬁ   able disease in Taiwan 
since 2002 (4). We reviewed reports 
and medical records of complicated 
pandemic (H1N1) 2009 virus 
infection, conﬁ   rmed by real-time 
reverse transcription PCR in women 
15–49 years of age who had onset 
of illness during July 1–December 
31, 2009. Data were obtained for 
demographics; pregnancy status and 
outcome; gestational age at illness 
onset; preexisting medical conditions; 
onset of illness; treatment; and 
severity, including intensive care unit 
(ICU) admission.
To calculate rates of complicated 
pandemic (H1N1) 2009 virus 
infection, we estimated the pregnant 
population during July 1–December 
31, 2009, by using the National Health 
Insurance computerized database 
for Taiwan (5). Women who were 
15–49 years of age and had been 
assigned International Classiﬁ  cation 
of Diseases, 9th Revision, Clinical 
Modiﬁ  cation (www.cdc.gov/nchs/icd/
icd9cm.htm), codes of V22* (normal 
pregnancy) and V23* (supervision of 
high-risk pregnancy) during the study 
were considered pregnant. Number of 
nonpregnant women was estimated by 
subtracting the calculated number of 
pregnant women from the number of 
women 15–49 years of age from 2009 
household registration data (6). We 
estimated 95% conﬁ  dence  intervals 
(CIs) for rates by using exact binomial 
methods.
During July 1–December 31, 
2009, data were reported for 10 
pregnant women and 138 nonpregnant 
women 15–49 years of age who had 
conﬁ   rmed, complicated pandemic 
(H1N1) 2009 virus infections. Dates 
of illness onset ranged from August 3 
through December 31, 2009. Median 
age of the 10 pregnant women was 24.5 
years (range 22–32 years), and median 
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